Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

10.1186/s12878-015-0028-2

Saved in:

Bibliographic Details
Main Authors:	Ong, S.-Y, Truong, H.-T.-T, Diong, C.P, Linn, Y.-C, Ho, A.Y.-L, Goh, Y.-T, Hwang, W.Y.-K
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	2020
Subjects:	aciclovir calcineurin inhibitor cotrimoxazole cytomegalovirus antigen pp65 foscarnet itraconazole posaconazole thymocyte antibody valaciclovir valganciclovir acute lymphoblastic leukemia acute myeloid leukemia adolescent adult age distribution aged Article blood toxicity controlled study creatinine blood level cytomegalovirus infection drug efficacy drug megadose drug monitoring drug safety female graft versus host reaction hematopoietic stem cell transplantation herpes zoster human human cell immunosuppressive treatment major clinical study male mycosis myelodysplastic syndrome nephrotoxicity neutropenic enterocolitis nonhodgkin lymphoma Pneumocystis pneumonia recurrent virus infection retrospective study risk benefit analysis treatment duration viral clearance virus load virus reactivation
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/180347
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Description
Summary:	10.1186/s12878-015-0028-2